Financial Risk Management (Tables)
|
12 Months Ended |
Mar. 31, 2026 |
| Disclosure of financial risk management [Abstract] |
|
| Information about how entity determined risk component designated as hedged item [text block] |
| | | | Market risk - foreign exchange | Recognized financial assets and liabilities denominated in foreign currencies. | Cash flow forecasting.Sensitivity analysis. | Foreign currencyforwards and foreign currency options | Market risk - interest rate | Borrowings at variable rates. | | Interest rate swaps.Asset-liability management. | Market risk - electricity prices | Highly probable forecast electricity purchases at spot price | Cash flow forecasting.Sensitivity analysis. | Fixed-price physical power purchase agreements | | Cash and cash equivalents, trade receivables, derivative financial instruments, debt instruments and contract assets. | Aging analysis. Credit ratings. Probability of default analysis. Stress testing. | Diversification of bankdeposits, credit limits,collateral, credit insurance and letters of credit.Investment guidelinesfor debt instruments. | | Borrowings and other liabilities | Rolling cash flow forecasts. Stress testing. | Availability of committed credit lines and borrowing facilities from multiple counterparties. Asset-liability management. |
|
| Disclosure of credit risk exposure [text block] |
The gross carrying amount of financial assets, net of any impairment losses recognized represents the maximum credit exposure. The maximum exposure to credit risk as of March 31, 2026 and 2025 was as follows:
|
| Disclosure of financial assets that are past due or impaired [Text Block] |
Allowances for impairment for trade receivables have been provided based on Expected Credit Loss Method adopting a simplified approach provided in IFRS 9. The ageing analysis of trade receivables has been considered from the due date for the practical expedient. The ageing of trade receivables, net of allowances, is given below:
|
| Disclosure of detailed information about maturity analysis for non-derivative financial assets [text block] |
The following are the contractual maturities of financial assets, including estimated interest receipts and excluding the impact of netting agreements: | | | | | | | | | | | | Non-derivative financial assets | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
*0 represents value less than rounding off norm adopted by the Group. As of March 31, 2025 | Carrying amount | | Contractual cash flows | | 0-12 months | | 1-3 years | | 3-5 years | | >5 years | Non-derivative financial assets | | | | | | | | | | | | Cash and bank balances | | | | | | | | | | | | Restricted Cash | | | | | | | | | | | | Trade receivables | | | | | | | | | | | | Other financial assets | | | | | | | | | | | | Investments | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | Non-derivative financial assets | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
| Disclosure of maturity analysis for non-derivative financial liabilities [text block] |
The following are the contractual maturities of financial liabilities, including estimated interest payments and excluding the impact of netting agreements: | | | | | | | | | | | | Non-derivative financial liabilities | | | | | | | | | | | | | | | | | | | | | | | | 6% Compulsorily Convertible Debentures | | | | | | | | | | | | 8.95% Non-Convertible Debentures | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Supplier finance arrangements | | | | | | | | | | | | | | | | | | | | | | | | Other financial liabilities | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | Non-derivative financial liabilities | | | | | | | | | | | | | | | | | | | | | | | | 6% Compulsorily Convertible Debentures | | | | | | | | | | | | 8.95% Non-Convertible Debentures | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Supplier finance arrangements | | | | | | | | | | | | | | | | | | | | | | | | Other financial liabilities | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | Non-derivative financial liabilities | | | | | | | | | | | | | | | | | | | | | | | | 6% Compulsorily Convertible Debentures | | | | | | | | | | | | 6% Non-Cumulative Compulsorily Convertible Preference Shares | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
| Disclosure of market risk [text block] |
The Group’s exposure to foreign currency risk as of March 31, 2026 was as follows: | All amounts in respective currencies as mentioned (in millions) | | | | | | | | | | | | | | | | | Cash and cash equivalents | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (6) | | (0) | | | | (0) | | (0) | | (0) | | (0) | | (0) | | | | | | | | | | | | | | | | | Net balance sheet exposure | | | (0) | | | | | | (0) | | (0) | | (0) | | (0) |
Note: 0 represents value less than the rounding off norm adopted by the Group. The Group’s exposure to foreign currency risk as of March 31, 2025 was as follows: | All amounts in respective currencies as mentioned (in millions) | | | | | | | | | | | | | | | Cash and cash equivalents | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (15) | | | | | | (0) | | (0) | | (0) | | (0) | | (3) | | | | | | | | | | | | | Net balance sheet exposure | (5) | | | | | | | | (0) | | (0) | | (0) |
Note: 0 represents value less than the rounding off norm adopted by the Group. The Group’s exposure to foreign currency risk as of March 31, 2024 was as follows: | All amounts in respective currencies as mentioned (in millions) | | | | | | | | | | | | | | | | | Cash and cash equivalents | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (8) | | | | | | (0) | | | | (0) | | | | | | (2) | | | | | | | | | | | | | | | Net balance sheet exposure | | | | | | | | | | | (0) | | | | |
|
| Sensitivity analysis for types of market risk [text block] |
| Other comprehensive income | | | | | | (167) | | | | | | | | |
|
| Disclosure of financial instruments by type of interest rate [text block] |
At the reporting date the interest rate profile of the Group’s interest –bearing financial instruments were as follows: | | | | | | | | | | | | | | - Fixed deposits with banks | | | | - Investment in debt securities | | | | | | | | | | | | | | | | | | | | Variable rate instruments | | | | | | | | | | | | | | | |
|
| Disclosure of detailed information about the changes in equity and net profit due to changes in base points of variable interest [text block] |
|